MEDLAB CLINICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.6 AUD | -.--% |
|
-5.04% | -.--% |
| Apr. 24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
| Feb. 29 | Medlab Clinical Limited Announces Change of Share Registry | CI |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 114.4 | 73.86 | 40.38 | 49.62 | 16.42 | 15.07 |
| Enterprise Value (EV) 1 | 94.58 | 63.39 | 33.65 | 37.88 | 12.36 | 14.85 |
| P/E ratio | -23 x | -9.04 x | -2.53 x | -3.47 x | -2.29 x | -2.22 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 20.6 x | 13.6 x | 14.2 x | 11.3 x | 12.8 x | 3.42 x |
| EV / Revenue | 17.1 x | 11.7 x | 11.8 x | 8.61 x | 9.63 x | 3.37 x |
| EV / EBITDA | -20.6 x | -7.65 x | -2.64 x | -3.01 x | -1.51 x | -2.51 x |
| EV / FCF | -30 x | -8.43 x | -5.84 x | -6.46 x | -2.34 x | -5.47 x |
| FCF Yield | -3.34% | -11.9% | -17.1% | -15.5% | -42.7% | -18.3% |
| Price to Book | 5 x | 4.91 x | 3.54 x | 3.28 x | 2.03 x | 11.8 x |
| Nbr of stocks (in thousands) | 1,387 | 1,407 | 1,795 | 2,281 | 2,281 | 2,284 |
| Reference price 2 | 82.50 | 52.50 | 22.50 | 21.75 | 7.200 | 6.600 |
| Announcement Date | 8/31/18 | 8/30/19 | 8/28/20 | 8/30/21 | 8/30/22 | 4/24/24 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 5.546 | 5.432 | 2.848 | 4.399 | 1.282 | 4.406 |
| EBITDA 1 | -4.591 | -8.283 | -12.75 | -12.6 | -8.163 | -5.924 |
| EBIT 1 | -4.703 | -8.431 | -13.37 | -12.79 | -8.331 | -6.636 |
| Operating Margin | -84.8% | -155.21% | -469.29% | -290.7% | -649.64% | -150.6% |
| Earnings before Tax (EBT) 1 | -4.758 | -8.174 | -13.49 | -12.4 | -8.388 | -6.433 |
| Net income 1 | -4.57 | -8.091 | -13.4 | -12.32 | -7.162 | -6.778 |
| Net margin | -82.4% | -148.95% | -470.42% | -280.12% | -558.5% | -153.84% |
| EPS 2 | -3.584 | -5.808 | -8.910 | -6.270 | -3.142 | -2.970 |
| Free Cash Flow 1 | -3.156 | -7.516 | -5.763 | -5.862 | -5.281 | -2.712 |
| FCF margin | -56.9% | -138.37% | -202.34% | -133.25% | -411.8% | -61.55% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/31/18 | 8/30/19 | 8/28/20 | 8/30/21 | 8/30/22 | 4/24/24 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 19.8 | 10.5 | 6.73 | 11.7 | 4.07 | 0.23 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -3.16 | -7.52 | -5.76 | -5.86 | -5.28 | -2.71 |
| ROE (net income / shareholders' equity) | -38.2% | -44.4% | -103% | -94.8% | -74.1% | -143% |
| ROA (Net income/ Total Assets) | -20.3% | -23.7% | -44% | -41.6% | -32.5% | -57.3% |
| Assets 1 | 22.56 | 34.19 | 30.47 | 29.63 | 22.02 | 11.82 |
| Book Value Per Share 2 | 16.50 | 10.70 | 6.350 | 6.640 | 3.540 | 0.5600 |
| Cash Flow per Share 2 | 14.70 | 8.130 | 5.050 | 5.890 | 2.280 | 0.1000 |
| Capex 1 | 0.1 | 0.34 | 0.24 | 0.08 | 0.03 | 0.02 |
| Capex / Sales | 1.74% | 6.27% | 8.53% | 1.89% | 2.23% | 0.37% |
| Announcement Date | 8/31/18 | 8/30/19 | 8/28/20 | 8/30/21 | 8/30/22 | 4/24/24 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 9.83M | |
| -2.23% | 103B | |
| +1.78% | 95.28B | |
| +1.46% | 22.15B | |
| -15.61% | 21.02B | |
| -8.58% | 18.15B | |
| -38.74% | 16.73B | |
| -12.76% | 16.05B | |
| +5.12% | 13.68B | |
| +36.08% | 12.17B |
- Stock Market
- Equities
- MDC Stock
- Financials Medlab Clinical Limited
